86-181-88938005
Product Name | Tadalafil |
CAS No. | 171596-29-5 |
Assay | 99.2% |
Molecular Formula | C22H19N3O4 |
Molecular Weight | 389.341 |
Description | White Crystalline Powder |
Storage | Shading, Confined Preservation |
Applications:
Tadalafil is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED) under the name Tadalafil, and under the name Adcirca for the treatment of pulmonary arterial hypertension.
Tadalafil's pharmacologic distinction is its longer half-life (17.50 hours) resulting in longer duration of action, and so partly responsible for "The Weekend Pill" sobriquet. Furthermore, the longer half-life is the basis for current investigation of tadalafil's daily therapeutic use in relieving pulmonary arterial hypertension.
Description:
Fluocinonide (Fluonex, Lidex, Lidex-E, Lonide, Lyderm, and Vanos) is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort.
Usage and Dosage:
Clinical application stage, through the self-made hand in capsule or tablet, The dosage is from 10 to 30 mg/day, according to the constitution of different dosage. Adjust the dosage according to the different physical.
The recommended dose is 10 mg,taking before having sex, not affected by eating.
If the effect is not significant,you can try to increase the dosage to 20 mg.Medication frequency limit for once a day. Don't continuous daily use Tadalafil.
Specification:
Items of analysis | Specification | Results |
Appearance | White crystalline powder | Conforms |
Identification | IR/HPLC | Conforms |
Specific rotation | +78°-+84° | +80.29° |
Heavy Metals | ≤20ppm | <20ppm |
Loss on drying | ≤0.5% | 0.1% |
Residue on ignition | ≤0.1% | 0.04% |
Single impurity | ≤0.3% | 0.15% |
Total impurity | ≤0.5% | <0.3% |
Assay | ≥99% | 99.79% |
Conclusion | Qualified |
Website:http://www.steroidchina.com/